Tek- But the cash problem could be solved by Seroquel approval next week. If it is approved, does that not put the dilution worries behind? I think it goes a long way to doing so.
Approval of Pristiq and/or Lamictal would be real big.
And yes Regabatin is shelved. Unless Pfizer fails and partners with us, Regabatin is likely going no where. I am realistic on that one.
IPCI has said it many times- "multiple shots on goal". That is what we have. How many shots on goal does PTIE have? How many have they already missed? Didn't a big name partner drop them too? Yet they almost have the same market cap as IPCI. I find that ridiculous.
Revenue from Focalin/Seroquel and other generics will be key for IPCI in the coming year. The writing is on the wall that they will have enough money to sustain. Yes, the gap from July until the first check from MNK could be a problem. But if they have to dilute a little via ATM or other means during that time, then so be it.
News 
Market Data 
Discover 
